摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[2-(2-methoxyethoxy)ethyl](methyl)amine | 124192-94-5

中文名称
——
中文别名
——
英文名称
[2-(2-methoxyethoxy)ethyl](methyl)amine
英文别名
2-(2-methoxyethoxy)-N-methylethanamine
[2-(2-methoxyethoxy)ethyl](methyl)amine化学式
CAS
124192-94-5
化学式
C6H15NO2
mdl
MFCD16107087
分子量
133.191
InChiKey
CKXAGUOIDSMMPP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    58 °C(Press: 9 Torr)
  • 密度:
    0.893±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.5
  • 重原子数:
    9
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    30.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    (苯基异腈)金(I)氯化物 、 [2-(2-methoxyethoxy)ethyl](methyl)amine二氯甲烷 为溶剂, 生成
    参考文献:
    名称:
    Gold(i)–isocyanide and gold(i)–carbene complexes as substrates for the laser decoration of gold onto ceramic surfaces
    摘要:
    我们制备了异氰酸金络合物 XAu(RNC)(X = 卤化物、假卤化物,R = 烷基、芳基)和水溶性羰基金络合物 XAuC(NHPh)[MeN(CH2CH2O)nMe] (X = Cl,n = 1â11),并对其进行了评估,将其作为在陶瓷上直接激光写金装饰的基底。
    DOI:
    10.1039/b617347k
  • 作为产物:
    参考文献:
    名称:
    Gold(i)–isocyanide and gold(i)–carbene complexes as substrates for the laser decoration of gold onto ceramic surfaces
    摘要:
    我们制备了异氰酸金络合物 XAu(RNC)(X = 卤化物、假卤化物,R = 烷基、芳基)和水溶性羰基金络合物 XAuC(NHPh)[MeN(CH2CH2O)nMe] (X = Cl,n = 1â11),并对其进行了评估,将其作为在陶瓷上直接激光写金装饰的基底。
    DOI:
    10.1039/b617347k
点击查看最新优质反应信息

文献信息

  • [EN] COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS<br/>[FR] COMPOSÉS ET PROCÉDÉS POUR LA DÉGRADATION CIBLÉE DE PROTÉINES CONTENANT UN BROMODOMAINE
    申请人:ARVINAS INC
    公开号:WO2017030814A1
    公开(公告)日:2017-02-23
    The present invention relates to bifunctional compounds, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present invention. In particular, the present invention is directed to compounds, which contain on one end a VHL ligand which binds to the ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. The present invention exhibits a broad range of pharmacological activities associated with compounds according to the present invention, consistent with the degradation/inhibition of targeted polypeptides.
    本发明涉及双功能化合物,其作为靶向泛素化的调节剂具有实用性,特别是根据本发明抑制各种多肽和其他蛋白质的化合物。具体而言,本发明涉及一端含有结合泛素连接酶的VHL配体,另一端含有结合靶蛋白的基团的化合物,使得靶蛋白靠近泛素连接酶以促使该蛋白的降解(和抑制)。根据本发明的化合物表现出与靶向多肽的降解/抑制一致的广泛的药理活性。
  • Derivatives of Amphotericin B
    申请人:Revolution Medicines, Inc.
    公开号:US20160304548A1
    公开(公告)日:2016-10-20
    Disclosed are derivatives of amphotericin B (AmB) characterized by improved therapeutic index compared to AmB. The AmB derivatives include C16 ureas, carbamates, and amides according to Formula (I); C3′-substituted C16 ureas, carbamates, and amides according to Formula (II); C16 acyls according to Formula (III); C2′epi-C16 ureas, carbamates, and amides according to Formula (IV); and C16 oxazolidinone derivatives according to Formula (V). Also disclosed are pharmaceutical compositions comprising the AmB derivatives, and therapeutic methods of using the AmB derivatives.
    披露了与AmB相比具有改善的治疗指数的Amphotericin B(AmB)衍生物。这些AmB衍生物包括根据公式(I)的C16脲、碳酸酯和酰胺;根据公式(II)的C3′-取代的C16脲、碳酸酯和酰胺;根据公式(III)的C16酰基;根据公式(IV)的C2′epi-C16脲、碳酸酯和酰胺;以及根据公式(V)的C16噁唑烷酮衍生物。还披露了包括这些AmB衍生物的药物组合物,以及使用这些AmB衍生物的治疗方法。
  • [EN] PROTEOLYSIS TARGETING CHIMERIC (PROTAC) COMPOUND WITH E3 UBIQUITIN LIGASE BINDING ACTIVITY AND TARGETING ALPHA-SYNUCLEIN PROTEIN FOR TREATING NEURODEGENERATIVE DISEASES<br/>[FR] COMPOSÉ CHIMÈRE CIBLANT LA PROTÉOLYSE (PROTAC) AYANT UNE ACTIVITÉ DE LIAISON À L'UBIQUITINE LIGASE E3 ET CIBLANT UNE PROTÉINE ALPHA-SYNUCLÉINE POUR LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES
    申请人:ARVINAS OPERATIONS INC
    公开号:WO2020041331A1
    公开(公告)日:2020-02-27
    The present disclosure relates to bifunctional compounds, which find utility as modulators of alpha-synuclein (target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a Von Hippel-Lindau, cereblon, Inhibitors of Apotosis Proteins or mouse double-minute homolog 2 ligand which binds to the respective E3 ubiquitin ligase and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/ inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure. Such diseases or disorders are alpha-synucleinopathies or neurodegenerative diseases associated with alpha-synuclein accumulation and aggregation, such as e.g. Parkinson Disease, Alzheimer's Disease, dementia, dementia with Lewy bodies or multiple system atrophy, in particular Parkinson's Disease.
    本公开涉及双功能化合物,其作为α-突触核蛋白(目标蛋白)的调节剂具有实用性。具体而言,本公开涉及包含一端为Von Hippel-Lindau、cereblon、凋亡抑制蛋白或鼠双分子同源物2配体的双功能化合物,该配体与相应的E3泛素连接酶结合,另一端为与目标蛋白结合的基团,使得目标蛋白靠近泛素连接酶以促使目标蛋白的降解(和抑制)。本公开展示了与目标蛋白的降解/抑制相关的广泛药理活性范围。本公开的化合物和组合物用于治疗或预防由目标蛋白聚集或积累导致的疾病或紊乱。这些疾病或紊乱是与α-突触核蛋白积累和聚集相关的α-突触核蛋白病或神经退行性疾病,例如帕金森病、阿尔茨海默病、痴呆症、带有Lewy小体的痴呆症或多系统萎缩,特别是帕金森病。
  • BENZODICYCLOALKANE DERIVATIVE, PREPARATION METHOD AND USE THEREOF
    申请人:SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD.
    公开号:US20190161468A1
    公开(公告)日:2019-05-30
    It is provided herein a benzobicycloalkane derivative, and a preparation method and use thereof. In particular, it is provided herein a compound of Formula (I), or a pharmaceutically acceptable salt, stereoisomer or solvate thereof, a preparation method, and a use thereof in preparation of drugs for treating pain.
    本文提供了一种苯并螺环烷衍生物,以及其制备方法和用途。具体而言,本文提供了一种式(I)化合物,或其药用可接受的盐、立体异构体或溶剂化合物,以及其制备方法,并用于制备治疗疼痛药物的用途。
  • SUBSTITUTED THIOPHENYL URACILS, SALTS THEREOF AND THE USE THEREOF AS HERBICIDAL AGENTS
    申请人:Syngenta Crop Protection AG
    公开号:US20200315174A1
    公开(公告)日:2020-10-08
    The invention relates to substituted thiophenyl uracils of general formula (I) or the salts (I) thereof, wherein the groups in general formula (I) are as defined in the description, and to the use thereof as herbicides, in particular for controlling weeds and/or weed grasses in crops of cultivated plants and/or as plant growth regulators for influencing the growth of crops of cultivated plants.
    本发明涉及取代噻吩基尿嘧啶的通式(I)或其盐(I),其中通式(I)中的基团如描述中定义,以及作为除草剂,特别是用于控制作物中的杂草和/或杂草草本的用途,以及作为植物生长调节剂用于影响栽培植物作物的生长。
查看更多

同类化合物

(N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷 顺,顺-丙二腈 非那唑啉 靛酚钠盐 靛酚 霜霉威盐酸盐 霜脲氰